Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
aminopyridine, 4
anxiety
carcinoma of lung
complications
confusional state, acute
disability rating scale, neurological
disability, neurological
dizziness
drug overdose
efficacy
electromyogram
gait disorder
iatrogenic neurologic disorders
medication error
multiple sclerosis
multiple sclerosis, treatment of
myasthenia gravis
myasthenia gravis, treatment of
myasthenic syndrome
myasthenic syndrome, treatment of
neurologic examination
neuromuscular junction
neuromuscular junction, abnormality of
neurotoxic
paresthesias
safety
seizure
status epilepticus
treatment of neurologic disorder
Showing articles 0 to 50 of 105 Next >>

Monitoring long-term Efficacy of Fampridine in Gait-Impaired Patients with Multiple Sclerosis
Neurol 88:832-841, Filli, L.,et al, 2017

Sustained-Release Oral Fampridine in Multiple Sclerosis: A Randomised, Double-Blind, Controlled Trial
Lancet 373:732-738, Goodman,A.D.,et al, 2009

4-Aminopyridine Toxicity with Unintentional Overdose in Four Patients with Multiple Sclerosis
Neurol 71:1833-1834, Burton,J.M.,et al, 2008

Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997

4-Aminopyridine in the Treatment of Patients with Multiple Sclerosis:Long-term Efficacy and Safety
Arch Neurol 51:292-296, Polman,C.H.,et al, 1994

The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover
Neurol 44:1054-1059, Bever,C.T.,et al, 1994

The Effect of 4-Aminopyridine on Clinical Signs in Multiple Sclerosis
Ann Neurol 32:123-130, vanDiemen,H.A.M.,et al, 1992

4-Aminopyridine in Multiple Sclerosis:Prolonged Administration
Neurol 41:1344-1348, Stefoski,D.,et al, 1991

Orally Administered 4-Aminopyridine Improves Clinical Signs in Multiple Sclerosis
Ann Neurol 27:186-192, Davis,F.A.,et al, 1990

4-Aminopyridine Improves Clinical Signs in Multiple Sclerosis
Ann Neurol 21:71-77, Stefoski,D.,et al, 1987

Treatment with Oral 4-aminopyridine in Disorders of Neuromuscular Transmission
Neurol 31:265-271, Murray,N.M.F.,et al, 1981

4-Aminopyridine-A New Drug Tested in the Treatment of Eaton-Lambert Syndrome
JNNP 40:1109, Lundh,H.,et al, 1977

Automated Idiopathic Normal Pressure Hydrocephalus Diagnosis via Artificial Intelligence-Based 3D T1 MRI Volumetric Analysis
AJNR 46:33-40, Lee,J.,et al, 2025

FUTURE-AI: International Consensus Guideline for Trustworthy and Deployable Artificial Intelligence in Healthcare
BMJ 388:e081554, Lekadir,K.,et al, 2025

Calibrating AI Reliance - A Physicians Superhuman Dilemma
JAMA Health Forum 6:e250106, Patil,S.V.,et al, 2025

Validation of an Artificial Intelligence-Powered Virtual Assistant for Emergency Triage in Neurology
Neurologist 30:155-163, Alessandro,L.,et al, 2025

General AI May Revolutionize Neurology 0 Or It Might be Bad
JAMA Neurol doi 10.1001/JAMANEUROL.2025.0905, Westover,M.B. & Westover,A.M., 2025

A Systematic Review and Meta-Analysis of Diagnostic Performance Comparison Between Generative AI and Physicians
NPJ Digital Medicine doi:10.1038/s41746-025-10543, Takita,H.,et al, 2025

Dedicated AI Expert System vs Generative AI with Large Language Model for Clinical Diagnosis
JAMA Network Open 8:e2512994, Feldman,M.J.,et al, 2025

Educational Strategies for Clinical Supervision of Artificial Intelligence Use
NEJM 393:786-797, Abdulnour,R-E. E.,et al, 2025

AI in Neurology: Everything, Everywhere, all at One PRT 2:Speech, Sentience, Scruples, and Service
Ann Neurol 98:431-447, Rizzo, M., 2025

Gait Analysis in Neurologic Disorders, Methodology, Applications and Clinical Considerations
Neurol 105:e214154, Ali,F.,et al, 2025

Neurological Diagnosis, Artificial Intelligence Compared with Diagnostic Generator
Neurologist doi.10.1097/NR.0000000000000560, Finelli,P.F., 2024

Hidden Metastatic Lung Tumour Diagnosed by AI
Lancet 403:1299, Muroya,D.,et al, 2024

Primary Central Nervous System Vasculitis
NEJM 391:1028-1037, Salvarani,C.,et al, 2024

FTC Regulation of AI-Generated Medical Disinformation
JAMA doi:10.1001/JAMA.2024.19971;2024, Haupt,C.E., & Marks,M., 2024

Large Language Models and the Degredation of the Medical Record
NEJM 391:1561-1564, McCoy,L.G.,et al, 2024

How Patients Are Using AI
BMJ 387:q2393, Stokel-Walker,C., 2024

Artificial Intelligence and Machine Learning in Clinical Medicine, 2023
NEjM 388:1201-1208,1220, Haug,C.H. & Drazen,J.M., 2023

Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine
NEJM 388:1233-1239, Lee,P., et al, 2023

The New Era of Automated Electroencephalogram Interpretation
JAMA Neurol 80:777-778, Kleen,J.K., & Guterman,E.L., 2023

Transformation of Undergraduate Medical Education in 2023
JAMA 330:1521-1522, Chang,B.S., 2023

Accuracy of a Generative Artificial Intelligence Model in a Complex Diagnostic Challenge
JAMA 330:78-79, Kanjee,Z.,et al, 2023

Improving Neurology Clinical Care with Natural Language Processing Tools
Neurol 101:1010-1018, Ge,W.,et al, 2023

Large Language Models in Neurology Research and Future Practice
Neurol 101:1058-1067, Romano,M.F.,et al, 2023

Will Generative Artificial Intelligence Deliver on Its Promise in Health Care?
JAMA doi.10.1001, Nov, Wachter R.M. & Brynjolfsson,E., 2023

Use of GPT-4 to Diagnose Complex Clinical Cases
NEJM AI doi:10.1056/AIp2300031, Eriksen,A.V.,et al, 2023

Study Finds ChatGPT Provides Inaccurate Responses to Drug Questions-Press Release
Am Soc Health Sys Pharm, Dec 5, Grossman,S., 2023

A New Case of Neuromyelitis Optica Spectrum Disorders with Unknown Fever and Subacute Cognitive Decline with Normal Images
Cureus 14:e24950, Furuya,K. & Itoh,M., 2022

Ethical Considerations in Surgical Decompression for Stroke
Stroke 53:2676-2682, Shlobin, N.A.,et al, 2022

Neuromyelitis Optica Spectrum Disorder
NEJM 387:631-639, Wingerchuk, D.M. & Lucchinetti, C.F., 2022

External Validation of e-ASPECTS Software for Interpreting Brain CT in Stroke
Ann Neurol 92:943-957, Mair,G.,et al, 2022

Digital Health
Stroke 52:351-355, Silva, G.S. & Schwamm, L.H., 2021

Sequential Bilateral Vision Loss in a Woman with Scalp Tenderness and Jaw Claudication
JAMA Neurol 78:878-879, Kaufman, A.R.,et al, 2021

The First Examination of Diagnostic Performance of Automated Measurement of the Callosal Angle in 1856 Elderly Patients and Volunteers Indicates that 12.4% of Exams Met the Criteria for Possible Normal Pressure Hydrocephalus
AJNR 42:1942-1948, Morzage, M.,et al, 2021

Next-Generation Artificial Intelligence for Diagnosis
JAMA doi:10.1001/JAMA/2021.22396, Dec, Adler-Milstein, J.,et al, 2021

Artificial Intelligence to Detect Papilledema from Ocular Fundus Photographs
NEJM 382:1687-1695,1760, Milea, D.,et al, 2020

Rapid Implementation of Virtual Neurology in Response to the COVID-19 Pandemic
Neurol 94:1077-1087, Grossman, S.N.,et al, 2020

Artificial Intelligence Applications in Stroke
Stroke 51:2573-2579, Mouridsen, K.,et al, 2020



Showing articles 0 to 50 of 105 Next >>